The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Open accessAbstract
Significance: Lysergic acid diethylamide (LSD), the prototypical “psychedelic,” may be unique among psychoactive substances. In the decades that followed its discovery, the magnitude of its effect on science, the arts, and society was unprecedented. LSD produces profound, sometimes life-changing experiences in microgram doses, making it a particularly powerful scientific tool. Here we sought to examine its effects on brain activity, using cutting-edge and complementary neuroimaging techniques in the first modern neuroimaging study of LSD. Results revealed marked changes in brain blood flow, electrical activity, and network communication patterns that correlated strongly with the drug’s hallucinatory and other consciousness-altering properties. These results have implications for the neurobiology of consciousness and for potential applications of LSD in psychological research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Such disruption is believed to be associated with the experience of ego dissolution [71].”
From Mindfulness meditation and psychedelics: potential synergies and commonalities (2023) · cites this paper as [71]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the field of psychedelic neuroscience, reduced mPFC-PCC connectivity as well as DMN deactivation and disintegration have been demonstrated post-acutely after the administration of psilocybin, LSD and ayahuasca (45, 46, 57), while long-term ayahuasca users demonstrated thinning of the PCC (117).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [46]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In contrast, arterial spin labeling (ASL) measurements of cerebral perfusion indicated that LSD (1) increased CBF in visual cortex of human volunteers [139].”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [139]
The cited source says what the claim attributes to it.
In the citing paper
“The increased CBF and the extent of the functional connectivity of the visual cortex correlated with the intensity of visual hallucinations; we suppose that anesthesia may have interfered in the effects of LSD (1) on CBF in the pig PET study.”
From Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. (2021) · cites this paper as [139]
The cited source says what the claim attributes to it.
In the citing paper
“Certain psychedelic studies have further correlated these transient connectivity changes within the DMN with subjective measures of drug-induced ego-dissolution (46, 115).”
From Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy (2021) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shaping Functional Architecture by Oscillatory Alpha Activity: Gating by Inhibition
Jensen, O., & Mazaheri, A. (2010) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2010.00186 · Cited by 3,237
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
(1995) · PubMed · Cited by 1,320
Carhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Self-citationPilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172
Self-citationPsilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750
Psychometric evaluation of the altered states of consciousness rating scale (OAV)
Studerus, E., Gamma, A., & Vollenweider, F. X. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012412 · Cited by 683
Research works printed but not linked: 1
- RR Monroe, RG Heath, Effects of lysergic acid and various derivatives on depth and cortical electrograms. J Neuropsychiatry 3, 75–82 (1961).
Cited by
Sorted by citations
Items 101–200 of 856
Consciousness in the cradle: on the emergence of infant experience
Bayne, T., Frohlich, J., Cusack, R., Moser, J., & Naci, L. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.08.018 · Cited by 106
Sanz, C., Zamberlán, F., Erowid, E., Erowid, F., & Tagliazucchi, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00007 · Cited by 113
Self-citationKadriu, B., Greenwald, M., Henter, I. D., Gilbert, J. R., Kraus, C., Park, L. T., & Zarate, C. A. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa087 · Cited by 99
An affective neuroscience model of boosting resilience in adults
Tabibnia, G. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.005 · Cited by 115
Behavioral Neurobiology of Psychedelic Drugs
(2018) · Current topics in behavioral neurosciences · doi:10.1007/978-3-662-55880-5 · Cited by 103
Martial, C., Cassol, H., Charland‐Verville, V., Pallavicini, C., Sanz, C., Zamberlán, F., Vivot, R. M., Erowid, F., Erowid, E., Laureys, S., et al. (2019) · Consciousness and Cognition · doi:10.1016/j.concog.2019.01.011 · Cited by 107
Self-citationClassical hallucinogens and neuroimaging: A systematic review of human studies
dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.026 · Cited by 107
Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?
Kočárová, R., Horáček, J., & Carhart-Harris, R. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.661233 · Cited by 96
Self-citationVarley, T. F., Carhart-Harris, R. L., Roseman, L., Menon, D. K., & Stamatakis, E. A. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117049 · Cited by 91
Self-citationLSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
Rodriguiz, R. M., Nadkarni, V., Means, C. R., Pogorelov, V. M., Chiu, Y.-T., Roth, B. L., & Wetsel, W. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96736-3 · Cited by 96
The acute effects of classic psychedelics on memory in humans
Healy, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05756-w · Cited by 102
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94
Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications
Kraehenmann, R. (2017) · Current Neuropharmacology · doi:10.2174/1573413713666170619092629 · Cited by 92
The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant
Sessa, B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4713-7 · Cited by 98
Self-citationGregorio, D. D., Enns, J. P., Núñez, N. A., Posa, L., & Gobbi, G. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.008 · Cited by 91
Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)
Nichols, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00043 · Cited by 91
Self-citationPsilocybin modulates functional connectivity of the amygdala during emotional face discrimination
Grimm, O., Krähenmann, R., Preller, K. H., Seifritz, E., & Vollenweider, F. X. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.03.016 · Cited by 96
Nichols, D. E., & Grob, C. S. (2018) · Forensic Science International · doi:10.1016/j.forsciint.2018.01.006 · Cited by 89
Self-citationPsychedelics and health behaviour change
Teixeira, P. J., Johnson, M. W., Timmermann, C., Watts, R., Erritzøe, D., Douglass, H. M., Kettner, H., & Carhart-Harris, R. L. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211008554 · Cited by 109
Self-citationBender, D., & Hellerstein, D. J. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06049-6 · Cited by 88
Psychedelics and the science of self-experience
Nour, M. M., & Carhart-Harris, R. L. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.194738 · Cited by 87
Self-citationPsychedelics, Sociality, and Human Evolution
Rodríguez Arce, J. M., & Winkelman, M. J. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.729425 · Cited by 86
Michaiel, A. M., Parker, P. R. L., & Niell, C. M. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.104 · Cited by 82
Psychedelics and music: neuroscience and therapeutic implications
Barrett, F. S., Preller, K. H., & Kaelen, M. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1484342 · Cited by 98
Self-citationLeptourgos, P., Fortier, M., Carhart-Harris, R. L., Corlett, P. R., Dupuis, D., Halberstadt, A. L., Kometer, M., Kozáková, E., Larøi, F., Noorani, T. N., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa117 · Cited by 90
Self-citationEffects of External Stimulation on Psychedelic State Neurodynamics
Mediano, P. A. M., Rosas, F. E., Timmermann, C., Roseman, L., Nutt, D., Feilding, A., Kaelen, M., Kringelbach, M. L., Barrett, A. B., Seth, A. K., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00289 · Cited by 84
Self-citationNeural Mechanisms and Psychology of Psychedelic Ego Dissolution
Stoliker, D., Egan, G. F., Friston, K. J., & Razi, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000508 · Cited by 96
Dark Classics in Chemical Neuroscience: Mescaline
Cassels, B. K., & Sáez-Briones, P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00215 · Cited by 85
Dakwar, E., Nunes, E. V., Hart, C. L., Hu, M. C., Foltin, R. W., & Levin, F. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.005 · Cited by 85
Lozano‐Soldevilla, D. (2018) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2018.00023 · Cited by 89
Deco, G., Perl, Y. S., Bocaccio, H., Tagliazucchi, E., & Kringelbach, M. L. (2022) · Communications Biology · doi:10.1038/s42003-022-03505-7 · Cited by 81
Self-citationZhang, J., Magioncalda, P., Huang, Z., Tan, Z., Hu, X., Hu, Z., Conio, B., Amore, M., Inglese, M., Martino, M., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby138 · Cited by 82
Brainstem Modulation of Large-Scale Intrinsic Cortical Activity Correlations
van den Brink, R. L., Pfeffer, T. A., & Donner, T. H. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00340 · Cited by 85
Decreased directed functional connectivity in the psychedelic state
Barnett, L., Muthukumaraswamy, S. D., Carhart-Harris, R. L., & Seth, A. K. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116462 · Cited by 83
Self-citationThe Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 92
Self-Organization Toward Criticality by Synaptic Plasticity
Zeraati, R., Priesemann, V., & Levina, A. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.619661 · Cited by 82
Acute subjective effects in LSD- and MDMA-assisted psychotherapy
Schmid, Y., Gasser, P., Oehen, P., & Liechti, M. E. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120959604 · Cited by 85
Hallucinations, somatic‐functional disorders of PD‐DLB as expressions of thalamic dysfunction
ONOFRJ, M. C., Espay, A. J., Bonanni, L., Pizzi, S. D., & Sensi, S. L. (2019) · Movement Disorders · doi:10.1002/mds.27781 · Cited by 79
Duan, W., Cao, D., Wang, S., & Cheng, J. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00375 · Cited by 81
A review on research and evaluation methods for investigating self-transcendence
Kitson, A., Chirico, A., Gaggioli, A., & Riecke, B. E. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.547687 · Cited by 76
Silverstein, S. M., & Lai, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.684720 · Cited by 94
Timmermann, C., Spriggs, M. J., Kaelen, M., Leech, R., Nutt, D., Moran, R., Carhart-Harris, R. L., & Muthukumaraswamy, S. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.039 · Cited by 75
Self-citationPreller, K. H., Schilbach, L., Pokorny, T., Flemming, J., Seifritz, E., & Vollenweider, F. X. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1939-17.2018 · Cited by 71
Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. A. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05391-0 · Cited by 85
Gingerich, J. (2022) · Ethics · doi:10.1086/720778 · Cited by 75
A complex systems perspective on psychedelic brain action
Girn, M., Rosas, F. E., Daws, R. E., Gallen, C. L., Gazzaley, A. H., & Carhart-Harris, R. L. (2023) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2023.01.003 · Cited by 79
Self-citationNeural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings
Pallavicini, C., Cavanna, F., Zamberlán, F., de la Fuente, L. A., Ilksoy, Y. A., Perl, Y. S., Arias, M., Romero, C., Carhart-Harris, R. L., Timmermann, C., et al. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120981384 · Cited by 90
Self-citationMurray, C. H., Tare, I., Perry, C., Malina, M., Lee, R., & de Wit, H. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05991-9 · Cited by 76
DMT alters cortical travelling waves
Alamia, A., Timmermann, C., Nutt, D. J., VanRullen, R., & Carhart-Harris, R. L. (2020) · eLife · doi:10.7554/elife.59784 · Cited by 97
Self-citationPharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
Holze, F., Duthaler, U., Vizeli, P., Müller, F., Borgwardt, S., & Liechti, M. E. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13918 · Cited by 73
Simulated visual hallucinations in virtual reality enhance cognitive flexibility
Rastelli, C., Greco, A., Kenett, Y. N., Finocchiaro, C., & Pisapia, N. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-08047-w · Cited by 76
An Integrated theory of false insights and beliefs under psychedelics
McGovern, H. T., Grimmer, H. J., Doss, M. K., Hutchinson, B. T., Timmermann, C., Lyon, A., Corlett, P. R., & Laukkonen, R. (2024) · Communications Psychology · doi:10.1038/s44271-024-00120-6 · Cited by 79
Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective
Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69
The Altered States Database: Psychometric Data of Altered States of Consciousness
Schmidt, T. T., & Berkemeyer, H. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01028 · Cited by 72
Winkelman, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.619890 · Cited by 55
Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin
Holze, F., Avedisian, I., Varghese, N., Eckert, A., & Liechti, M. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.711255 · Cited by 73
Johnston, J. N., Kadriu, B., Allen, J., Gilbert, J. R., Henter, I. D., & Zarate, C. A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109422 · Cited by 73
Transformative experience and informed consent to psychedelic-assisted psychotherapy
Jacobs, E. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1108333 · Cited by 75
Luppi, A. I., Golkowski, D., Ranft, A., Ilg, R., Jordan, D., Menon, D. K., & Stamatakis, E. A. (2021) · Human Brain Mapping · doi:10.1002/hbm.25405 · Cited by 62
Mertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65
Gandy, S., Forstmann, M., Carhart-Harris, R. L., Timmermann, C., Luke, D. P., & Watts, R. (2020) · Health Psychology Open · doi:10.1177/2055102920978123 · Cited by 70
Self-citationClinically relevant acute subjective effects of psychedelics beyond mystical experience
Yaden, D. B., Goldy, S. P., Weiss, B., & Griffiths, R. R. (2024) · Nature Reviews Psychology · doi:10.1038/s44159-024-00345-6 · Cited by 67
Acute LSD effects on response inhibition neural networks
Schmidt, A., Müller, F., Lenz, C., Dolder, P. C., Schmid, Y., Zanchi, D., Lang, U. E., Liechti, M. E., & Borgwardt, S. (2017) · Psychological Medicine · doi:10.1017/s0033291717002914 · Cited by 65
Defining Transformative Experiences: A Conceptual Analysis
Chirico, A., Pizzolante, M., Kitson, A., Gianotti, E., Riecke, B. E., & Gaggioli, A. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.790300 · Cited by 75
Luppi, A. I., Hansen, J. Y., Adapa, R., Carhart-Harris, R. L., Roseman, L., Timmermann, C., Golkowski, D., Ranft, A., Ilg, R., Jordan, D., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf8332 · Cited by 68
Self-citationThe role of fMRI in drug development
Carmichael, O. T., Schwarz, A. J., Chatham, C. H., Scott, D., Turner, J. A., Upadhyay, J., Coimbra, A., Goodman, J. A., Baumgartner, R., English, B. A., et al. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.11.012 · Cited by 60
Atasoy, S., Vohryzek, J., Deco, G., Carhart-Harris, R. L., & Kringelbach, M. L. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.009 · Cited by 59
Self-citationSafety pharmacology of acute LSD administration in healthy subjects
Holze, F., Caluori, T. V., Vizeli, P., & Liechti, M. E. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05978-6 · Cited by 65
Unifying turbulent dynamics framework distinguishes different brain states
Escrichs, A., Perl, Y. S., Uribe, C., Càmara, E., Türker, B., Pyatigorskaya, N., López‐González, A., Pallavicini, C., Panda, R., Annen, J., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03576-6 · Cited by 66
Self-citationPsychedelics and Consciousness: Distinctions, Demarcations, and Opportunities
Yaden, D. B., Johnson, M. W., Griffiths, R. R., Doss, M. K., Garcia‐Romeu, A., Nayak, S. M., Gukasyan, N., Mathur, B. N., & Barrett, F. S. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab026 · Cited by 69
Pharmacokinetics of N,N-dimethyltryptamine in Humans
Good, M., Joel, Z., Benway, T. A., Routledge, C. A., Timmermann, C., Erritzøe, D., Weaver, R., Allen, G., Hughes, C., Topping, H., et al. (2023) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-023-00822-y · Cited by 71
Neuropharmacological modulation of the aberrant bodily self through psychedelics
Ho, J. T., Preller, K. H., & Lenggenhager, B. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.006 · Cited by 62
Chowdhury, A., van Lutterveld, R., Laukkonen, R., Slagter, H. A., Ingram, D. M., & Sacchet, M. D. (2023) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2023.108694 · Cited by 68
Potential Differences in Psychedelic Actions Based on Biological Sex
Shadani, S., Conn, K., Andrews, Z. B., & Foldi, C. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae083 · Cited by 62
Roseman, L., Sereno, M. I., Leech, R., Kaelen, M., Orbán, C., McGonigle, J., Feilding, A., Nutt, D., & Carhart-Harris, R. L. (2016) · Human Brain Mapping · doi:10.1002/hbm.23224 · Cited by 59
Self-citationSpectral signatures of serotonergic psychedelics and glutamatergic dissociatives
Pallavicini, C., Vilas, M. G., Villarreal, M. F., Zamberlán, F., Muthukumaraswamy, S. D., Nutt, D., Carhart-Harris, R. L., & Tagliazucchi, E. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.053 · Cited by 60
Self-citationModel-based whole-brain effective connectivity to study distributed cognition in health and disease
Gilson, M., Zamora‐López, G., Pallarés, V., Adhikari, M. H., Senden, M., Campo, A. T., Mantini, D., Corbetta, M., Deco, G., & Insabato, A. (2019) · Network Neuroscience · doi:10.1162/netn_a_00117 · Cited by 62
Pattern breaking: a complex systems approach to psychedelic medicine
Hipólito, I., Mago, J., Rosas, F. E., & Carhart-Harris, R. L. (2023) · Neuroscience of Consciousness · doi:10.1093/nc/niad017 · Cited by 70
Self-citationModulatory effects of ayahuasca on personality structure in a traditional framework
Netzband, N., Ruffell, S., Linton, S., Tsang, W., & Wolff, T. J. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05601-0 · Cited by 56
Serotonin Decreases the Gain of Visual Responses in Awake Macaque V1
Seillier, L., Lorenz, C., Kawaguchi, K., Ott, T., Nieder, A., Pourriahi, P., & Nienborg, H. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1339-17.2017 · Cited by 57
Elsey, J. W. B. (2017) · Drug Science Policy and Law · doi:10.1177/2050324517723232 · Cited by 57
Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity
Glazer, J. E., Murray, C. H., Nusslock, R., Lee, R., & de Wit, H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01479-y · Cited by 56
Aqil, M., & Roseman, L. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109300 · Cited by 63
Self-citationA whole-brain model of the neural entropy increase elicited by psychedelic drugs
Herzog, R. A., Mediano, P. A. M., Rosas, F. E., Lodder, P., Carhart-Harris, R. L., Perl, Y. S., Tagliazucchi, E., & Cofré, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-32649-7 · Cited by 58
Self-citationSANTOS, R. G. D., & Hallak, J. E. C. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.053 · Cited by 66
Beyond the veil of duality—topographic reorganization model of meditation
Cooper, A. C., Ventura, B., & Northoff, G. (2022) · Neuroscience of Consciousness · doi:10.1093/nc/niac013 · Cited by 60
Psychedelic pleasures: An affective understanding of the joys of tripping
Bøhling, F. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.07.017 · Cited by 62
The Pharmacology of Visual Hallucinations in Synucleinopathies
Russo, M., Carrarini, C., Dono, F., Rispoli, M. G., Pietro, M. D., Stefano, V. D., Ferri, L., Bonanni, L., Sensi, S. L., & ONOFRJ, M. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01379 · Cited by 58
Gallimore, A. R., & Strassman, R. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00211 · Cited by 56
Fingelkurts, A. A., Fingelkurts, A. A., & Kallio-Tamminen, T. (2021) · Cognitive Neurodynamics · doi:10.1007/s11571-021-09719-5 · Cited by 54
Understanding brain states across spacetime informed by whole-brain modelling
Vohryzek, J., Cabral, J., Vuust, P., Deco, G., & Kringelbach, M. L. (2022) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2021.0247 · Cited by 56
Effective Connectivity of Functionally Anticorrelated Networks Under Lysergic Acid Diethylamide
Stoliker, D., Novelli, L., Vollenweider, F. X., Egan, G. F., Preller, K. H., & Razi, A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.07.013 · Cited by 57
Riga, M. S., Lladó-Pelfort, L., Artigas, F., & Celada, P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.049 · Cited by 50
Burt, J. B., Preller, K. H., Demirtaş, M., Ji, J. L., Krystal, J. H., Vollenweider, F. X., Anticevic, A., & Murray, J. D. (2021) · eLife · doi:10.7554/elife.69320 · Cited by 48
Husain, M. I., Ledwos, N., Fellows, E., Baer, J., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Castle, D. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1076459 · Cited by 50
Separable gain control of ongoing and evoked activity in the visual cortex by serotonergic input
Azimi, Z., Barzan, R., Spoida, K., Surdin, T., Wollenweber, P., Mark, M. D., Herlitze, S., & Jancke, D. (2020) · eLife · doi:10.7554/elife.53552 · Cited by 57
Psychedelic drugs and perception: a narrative review of the first era of research
Aday, J. S., Wood, J. R., Bloesch, E. K., & Davoli, C. C. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0094 · Cited by 55
Neural Correlates of the Shamanic State of Consciousness
Huels, E. R., Kim, H., Lee, U., Bel-Bahar, T., Colmenero, A. V., Nelson, A., Blain-Moraes, S., Mashour, G. A., & Harris, R. E. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.610466 · Cited by 52
Barrett, F. S., Preller, K. H., Herdener, M., Janata, P., & Vollenweider, F. X. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx257 · Cited by 55
Doss, M. K., May, D. G., Johnson, M. W., Clifton, J. M., Hedrick, S. L., Prisinzano, T. E., Griffiths, R. R., & Barrett, F. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-73216-8 · Cited by 50
Metadata
- Authors
- Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., Leech, R., Williams, L. T., Williams, T. M., Bolstridge, M., Sessa, B., McGonigle, J., Sereno, M. I., Nichols, D., Hellyer, P. J., Hobden, P., Evans, J., Singh, K. D., Wise, R. G., Curran, H. V., Feilding, A., & Nutt, D. J.
- Affiliations
- Imperial College London (GB)
- University of Auckland (NZ)
- Cardiff University (GB)
- Goethe University Frankfurt (DE)
- McGill University (CA)
- Centre for Neuropsychopharmacology, Department of Medicine, Imperial College London, W12 0NN, London, United Kingdom;
- Department of Psychiatry, University of Bristol, BS8 2BN, Bristol, United Kingdom;
- University College London (GB)
- University of North Carolina at Chapel Hill (US)
- Beckley Foundation (GB)
- ORCID
- Carhart-Harris, Robin L.
- Muthukumaraswamy, Suresh
- Roseman, Leor
- Kaelen, Mendel
- Droog, Wouter
- Murphy, Kevin
- Tagliazucchi, Enzo
- Schenberg, Eduardo E.
- Leech, Robert
- Sessa, Ben
- McGonigle, John
- Sereno, Martin I.
- Nichols, David
- Hellyer, Peter J.
- Evans, John
- Singh, Krish D.
- Wise, Richard G.
- Curran, H. Valerie
- Feilding, Amanda
- Nutt, David J.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2016-04-11
- Volume
- 113
- Issue
- 17
- Pages
- 4853-4858
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4855588
- OpenAlex
- W2336389811
- Cited by
- 859
- References
- 47
- Citations by year
- 2026: 79 · 2025: 85 · 2024: 110 · 2023: 112 · 2022: 83 · 2021: 85 · 2020: 67 · 2019: 70 · 2018: 74 · 2017: 64 · 2016: 29
- FWCI
- 105.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- BIROn (Birkbeck, University of London) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (WT090199, 200804/Z/16/Z)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cognitive Neuroscience › Hallucinations in medical conditions
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- lysergic acid diethylamide, LSD, psychedelics, visual hallucinations, ego dissolution, visual cortex, primary visual cortex, cerebral blood flow, alpha power, functional connectivity, parahippocampal cortex, retrosplenial cortex, consciousness, resting-state brain activity
- MeSH terms
- Brain, Brain Mapping, Cerebrovascular Circulation, Consciousness, Hallucinations, Hallucinogens, Humans, Lysergic Acid Diethylamide, Magnetic Resonance Imaging, Nerve Net, Synaptic Transmission, Oxygen, Spin Labels, Magnetoencephalography, Receptor, Serotonin, 5-HT2A, Serotonin 5-HT2 Receptor Agonists, Connectome, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
